Dermata Therapeutics, Inc.
USD0.01
-0.00 (-24.75%)
CEO
Gerald T. Proehl
IPO Date
2021-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$0.02
Market Cap
$0.00B
Volume
0.00M
| 10,000 |
| $0.61 |
| 5 Jan 2024 | WIERENGA WENDELL | director | A-Award | Acquired | 10,000 | $0.61 |
| 5 Jan 2024 | Mento Steven J | director | A-Award | Acquired | 10,000 | $0.61 |
| 5 Jan 2024 | FISHER MARY | director | A-Award | Acquired | 10,000 | $0.61 |
| 5 Jan 2024 | PROEHL GERALD T | director, officer: President, CEO and Chairman | A-Award | Acquired | 125,000 | $0.61 |
| 5 Jan 2022 | HALE DAVID F | director | A-Award | Acquired | 5,000 | $1.88 |
| 5 Jan 2022 | Scott Kathleen D. | director | A-Award | Acquired | 5,000 | $1.88 |
| 5 Jan 2022 | WIERENGA WENDELL | director | A-Award | Acquired | 5,000 | $1.88 |
| 5 Jan 2022 | Mento Steven J | director | A-Award | Acquired | 5,000 | $1.88 |